Myomo Inc (MYO)
4.66
-0.19
(-3.92%)
USD |
NYAM |
Nov 15, 16:00
4.69
+0.03
(+0.64%)
After-Hours: 20:00
Myomo Research and Development Expense (TTM): 4.090M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
Date | Value |
---|---|
September 30, 2024 | 4.090M |
June 30, 2024 | 3.559M |
March 31, 2024 | 3.116M |
December 31, 2023 | 2.636M |
September 30, 2023 | 2.258M |
June 30, 2023 | 2.231M |
March 31, 2023 | 2.300M |
December 31, 2022 | 2.482M |
September 30, 2022 | 2.770M |
June 30, 2022 | 2.721M |
March 31, 2022 | 2.688M |
December 31, 2021 | 2.555M |
September 30, 2021 | 2.186M |
June 30, 2021 | 1.890M |
March 31, 2021 | 1.688M |
December 31, 2020 | 1.669M |
Date | Value |
---|---|
September 30, 2020 | 1.693M |
June 30, 2020 | 1.780M |
March 31, 2020 | 1.810M |
December 31, 2019 | 1.750M |
September 30, 2019 | 1.837M |
June 30, 2019 | 1.853M |
March 31, 2019 | 1.913M |
December 31, 2018 | 1.839M |
September 30, 2018 | 1.666M |
June 30, 2018 | 1.546M |
March 31, 2018 | 1.767M |
December 31, 2017 | 1.752M |
September 30, 2017 | 1.802M |
June 30, 2017 | 1.710M |
March 31, 2017 | 1.260M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
1.669M
Minimum
Dec 2020
4.090M
Maximum
Sep 2024
2.394M
Average
2.279M
Median
Research and Development Expense (TTM) Benchmarks
Cutera Inc | 18.38M |
IRIDEX Corp | 6.272M |
Stereotaxis Inc | 9.182M |
Electromed Inc | 0.656M |
Axogen Inc | 29.23M |